KKKonstantin I. Kulaev

Konstantin I. Kulaev

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Konstantin I. Kulaev has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Application of artificial intelligence in assessing the size of colon tumors during endoscopic examination

    by K. I. Kulaev, A. V. Vazhenin, A. V. Privalov, E. A. Pushkarev, K. S. Zuykov, I. A. Popova, V. E. Samarkin, E. V. Alkhanov, D. M. Kutuzov, A. I. Kulaev, et al.

    Introduction. The risk of malignancy of precancerous colonic lesions directly depends on the size of the neoplasms detected during colonoscopy. According to various authors, neoplasms up to 2.0 cm in diameter have a 12.5% risk of harboring malignant cells. If the neoplasm is larger than 2.0 cm, the risk of malignancy increases significantly and, according to various authors, ranges from 31 to 57%. The endoscopist’s subjective assessment of neoplasm size often does not correspond to the actual size, leading to inappropriate treatment decisions. Aim. To develop and evaluate the effectiveness of a hardware-based subsystem for measuring the size of colonic neoplasms (AI-assisted neoplasm size estimation, AIANSE) during colonoscopy with AI-assisted colonoscopy detection (AIAC). Materials and methods. From 2022 to 2024, the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine, in collaboration with the Russian company EVA Lab, developed and implemented a clinical decision support system based on artificial intelligence algorithms. The study included 1,763 patients, from whom approximately 27,000 frames were labeled. Results. Computer processing of endoscopic images demonstrated its effectiveness in both tumor detection and tumor size estimation. This is confirmed by comparing colonoscopy image analysis data with the actual dimensions of the neoplasms determined after surgical treatment. The system possesses self-learning capabilities, as evidenced by the increase in specificity (from 63% to 70%), sensitivity (from 64% to 70%), and accuracy (from 66% to 71%) between 2022 and 2024. Conclusions. AIANSE, a computer-based tumor analysis and size measurement system, was developed for the first time. This system demonstrated its effectiveness in tumor size estimation, with an accuracy of 71%. This development demonstrated its greatest effectiveness in measuring tumor sizes of 5 mm in diameter, with an accuracy of 76%.

  • The methodological aspects and results of combined tracheal and esophageal stenting in locally advanced malignant tumors of the lung, esophagus, and mediastinum. A multicenter study

    by E.A. Drobyazgin, S.S. Pirogov, L.V. Telegina, K.I. Kulaev, Yu.V. Chikinev, S.E. Krasilnikov

    Objective. To assess the results of combined stenting of the trachea, bronchi, and esophagus on the basis of data from several medical research centers in Russia. Subjects and methods. In the period from 2010 to 2021, combined tracheal and esophageal stenting was performed in 20 patients aged 36 to 82 years (mean age 59.45±11.38 years). Among the patients, there were 15 men and 5 women. Esophageal cancer was diagnosed in 13 patients; recurrence in esophageal cancer after surgical treatment (Lewis surgery) in 2; lung cancer in 3, recurrence in lung cancer in 1, and B-cell lymphoma in 1. The decision to place the first stent depended on the severity of symptoms of dysphagia or respiratory failure. Results. At stage 1, thirteen (65%) and 7 (35%) patients underwent endoscopic surgery (esophageal and tracheal stenting, respectively). The second stent was inserted within 24 hours to 9 months (mean 98.8±87.8 days). Tracheal and esophageal stentings were simultaneously performed in 2 (10%) patients for several hours on the same day. In all cases, the tracheal and esophageal patency was restored, which could significantly improve quality of life in all cases and continue treatment in 12 patients. Complications occurred in 8 (40%) patients. All the complications were diagnosed and successfully corrected using endoscopic technologies. The patients’ lifespan after the second stent insertion was 30 to 330 days (mean 144.75±93.26 days). The patients’ total lifespan after intervention was 31 to 510 days (mean 243.55±124.61 days). Conclusion. Combined stenting is an effective and relatively safe endoscopic operation that improves quality of life in the patients. Most of the complications that occur during and after interventions can be eliminated using endoscopic technologies.

  • Open Access

    Effectiveness of a modified biopsy technique in endobronchial ultrasound (EBUS) in the diagnosis of peripheral lung neoplasms: results of a clinical study

    by E. A. Pushkarev, A. V. Vazhenin, K. I. Kulaev, I. M. Yusupov, K. S. Zuikov, I. A. Popova

    Introduction. The problem of lung malignant neoplasms diagnosis is extremely urgent. Verification of peripheral lung malignancies using ultrasound bronchoscopy does not exceed 70.6 %.The aim of the work is to demonstrate an increase in the verification of peripheral lung malignancies by endobronchial lung ultrasound examination.Materials and methods The study was conducted on the basis of the endoscopic department of the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine from 2019 to 2021, in which 142 patients were included. The patients were divided into 2 groups. The main group included 68 patients whose examination included fibrobronchoscopy with endo ultrasound with biopsy according to a modified technique. The comparison group included 74 patients who underwent ultrasound bronchoscopy with biopsy according to the standard technique. The manipulation time with biopsy according to the standard technique ranged from 12 to 42 minutes, on the average 29 ± 5 minutes. Ultrasound bronchoscopy with biopsy to the modified technique lasted from 14 to 44 minutes, on average – 30 ± 5 minutes.Results The modified technique of biopsy with endosonographic control of endoscopic instrument position in the pathological focus during ultrasound bronchoscopy allows to increase the percentage of peripheral lung malignant neoplasms verification by 19.8% (p < 0.05). Ultrasound bronchoscopy with biopsy according to a modified technique is a relatively safe manipulation, complications were detected in 2.9 % of patients and were successfully treated conservatively.Discussion Endobronchial ultrasound examination of the lungs is a sufficiently effective and informative technique. Introduction of modified biopsy technique into clinical practice and its wide application will allow to replace more invasive and traumatic diagnostic procedures, to increase informative value of ultrasound bronchoscopy.Conclusion The use of a modified biopsy technique during ultrasound bronchoscopy will increase the verification by 19.8 % (p < 0.05), thus allowing to reduce the period of examination of patients and prescribe antitumor treatment earlier.


  • Open Access

    Improving the quality of diagnosis and verification of peripheral lung neoplasms by using a modified biopsy technique for ultrasonic bronchoscopy (EBUS)

    by Evgeniy A. Pushkarev, Andrey V. Vazhenin, Konstantin I. Kulaev, Ildar M. Yusupov, Konstantin S. Zuykov, Inna A. Popova

    BACKGROUND: The problem of diagnosis and treatment of malignant neoplasms of the lungs is extremely relevant. Verification of the malignant process in the case of peripheral localization of the neoplasm in the lung when using ultrasound bronchoscopy does not exceed 70.6%. AIMS: This study aimed to improve the effectiveness of ultrasound bronchoscopy in the State Medical Institution Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine by introducing into clinical practice a modified biopsy technique for ultrasound bronchoscopy. The technique is patented, patent for invention no. RU2719666 C1. MATERIALS AND METHODS: From 2019 to 2021, a study was conducted based on the endoscopic department of the State Medical Institution Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine, which included 137 patients. The patients were divided into two groups: the main group included 66 patients in whose examination FBS with endoussis with biopsy by a modified technique was used; the comparison group included 71 patients who underwent ultrasound bronchoscopy with biopsy by a standard technique. The time of biopsy manipulation according to the standard procedure ranged from 14 to 41 min, averaging 305 min. Ultrasound bronchoscopy with biopsy by a modified technique lasted from 16 to 45 minutes, on average 315 min. RESULTS: In the main group, where FBS with ENDOUSSI with biopsy was used in the diagnosis of patients using a modified technique with endosonographic control of the position of the endoscopic instrument in the pathological focus, the diagnosis of malignant neoplasm was verified in 52 patients (in 78.8% of cases). In the comparison group, where the standard biopsy technique was used in patients with ultrasound bronchoscopy, the diagnosis of malignant neoplasm was verified in 41 patients (in 57.7% of cases). Thus, the verification of peripheral lung malignancies when using a modified biopsy technique increases by 21.1% (p 0.05). FBS with endoussis with biopsy using a modified technique is satisfactorily tolerated by patients and is a relatively safe manipulation. CONCLUSION: modified biopsy technique developed by us with endosonographic control of the position of the endoscopic instrument in the pathological focus during ultrasound bronchoscopy makes it possible to increase the percentage of verification of peripheral lung malignancies by 21.1% (p 0.05). The introduction and widespread use of the modified biopsy technique for ultrasound bronchoscopy in the diagnosis of peripheral lung malignancies will reduce the time of examination of patients and prescribe antitumor treatment earlier.

    • 1 January 2011
      • Vol. 170  (6) , 76-7

    [First experience with submucous endodissection of the duodenum bulb carcinoid].

    by V N Korolev, A V Vazhenin, K S Zuĭkov, I Iu Surovtsev, K I Kulaev

    • 1 January 2011
      • No. 10,p. 59-64

    [Transesophageal ultrasonography in the diagnosis of malignant tumors of the mediastinum].

    by V N Korolev, A V Vazhenin, A Iu Kinzerskiĭ, I Iu Surovtsev, K I Kulaev

    To assess transesophageal ultrasonography capabilities in diagnosis of mediastinal malignant tumors. Technique of radial transesophageal ultrasonography was used to diagnose mediastinal malignancy in 157 patients. Method of amplitude hystography was employed to assess lymph nodes. In 84 cases diagnosis had histological confirmation. In 61 case out of 84 (73%) diagnosis was true. In of lymph nodes without primary tumor in the lung diagnosis was true in 72% (26 cases out of 36) and with primary tumor in 73% (35 cases out of 48). Assessment of lymph nodes sized 30 mm and more was correct in 92% (11 cases out of 12) and much higher than for lymph nodes sized less 30 mm in diameter (69%, 50 out of 72 [p < 0.001, chi2]). Correct diagnosis for lymph nodes less than 10 mm in diameter was achieved in 65% (13 out of 20) [p = 0.44, chi2], for diameter 10-20 mm accuracy was 71% (22 cases out of 31) [p = 0.96, chi2] and similar to the one for diameter 20-30 mm assessment. Location of lesion proved to be important. For lymph nodes of 3, 7, 8, 9 zones (ATS classification) precision was much higher than for other locations. There were no adverse events during the study. Transesophageal ultrasonography with the use electronic radial detector is effective an safe method of mediastinal lymph nodes and primary tumors assessment.